💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Atara Biotherapeutics, Inc. (ATRA)
« Back to company indexATRA Chatter Timeline
Stock Ticker for ATRA
Most Active Tweeters for ATRA
| User | Tweets |
|---|---|
| @ShortAlgoTrades | 8 |
| @Tickeron | 4 |
| @FlashAlert_me | 3 |
| @newsfilterio | 3 |
| @stock_titan | 2 |
Recent Tweets for ATRA
 |
@formwhisperscom #FWSells $ATRA Dupont Jakob, EVP, Head of R&D of Atara Biotherapeutics, Inc. sold 5,000 shares on 2021-12-01. https://t.co/OiMnJa21gP 4:12am |
 |
@newsfilterio $41,800.00 of shares sold by Dupont Jakob (EVP, Head of R&D), reported in a new form 4 filed with the SEC $ATRA https://t.co/wgEbvPvklI 4:12am |
 |
@mehabecapital $ATRA @ 17.09 (-5.11%) : Atara Biotherapeutics announces inducement grants to new employees https://t.co/ve3loR372n 3:12am |
 |
@mediasentiment $ATRA new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 944 December 3rd 2021, 11:12pm |
 |
@Tickeron $ATRA in Downtrend: its price may decline as a result of having broken its higher Bollinger Band on November 1, 202… https://t.co/ZUMWfaQn3X December 3rd 2021, 11:12pm |
|
@mehabecapital $ATRA @ 17.09 (-5.11%) : Atara Biotherapeutics announces inducement grants to new employees https://t.co/szcqwAIPGS December 3rd 2021, 9:12pm |
 |
@ZinvestZ @Amarillo_Slim1 Ever look at $atra? December 3rd 2021, 9:12pm |
 |
@fintel_io Insider Jakob Dupont reports selling 5,000 shares of $ATRA for a total cost of $89,688.50 https://t.co/VaHZ2W22T1 #FNTL December 3rd 2021, 9:12pm |
 |
@FlashAlert_me $ATRA [15s. delayed]: Issued Press Release on December 03, 16:01:00: Atara Biotherapeutics Reports Inducement Grant… https://t.co/KhXd7F9V9z December 3rd 2021, 9:12pm |
 |
@otcdynamics $ATRA Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://t.co/pD6UX6rIG7 December 3rd 2021, 9:12pm |
|
@newsfilterio Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635 $ATRA https://t.co/6WlCZHJ1tV December 3rd 2021, 9:12pm |
 |
@StockNewsBot2 $ATRA Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://t.co/hD5FLcCovG December 3rd 2021, 9:12pm |
 |
@quantisnow $ATRA ? Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://t.co/321OsYs81B 45 seconds delayed. December 3rd 2021, 9:12pm |
 |
@phasefivebot $ATRA Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://t.co/lrgoVxoJOU December 3rd 2021, 9:12pm |
 |
@stock_titan $ATRA Atara Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://t.co/XIjNywWnJK December 3rd 2021, 9:12pm |
 |
@jdupontmd RT @MarcJacksonLA: https://t.co/oCstLpJA8G | $ATRA European Medicines Agency (EMA) Validates Atara Biotherapeutics' Marketing Authorization… December 3rd 2021, 7:12pm |
 |
@ShortAlgoTrades $ATRA Waiting for BUY signal on ATRA with https://t.co/tTvUcCODHL https://t.co/XxDfv8Vw5p December 1st 2021, 9:12pm |
 |
@StockConsultant $ATRA Atara Biotherapeutics stock with a breakout watch above 18.6 , see https://t.co/1Ycwg9KpEk https://t.co/S6o0oBSCor December 1st 2021, 4:12pm |
 |
@equity_newswire $ATRA European Medicines Agency (EMA) Validates Atara Biotherapeutics' Marketing Authorization Application for Tabe… https://t.co/miWyW00z43 December 1st 2021, 2:12am |
|
@ShortAlgoTrades $ATRA waiting for buy signal on ATRA https://t.co/QTxipWYq17 November 30th 2021, 4:11pm |
 |
@gcassidy718 $ATRA European Medicines Agency (EMA) Validates Atara Biotherapeutics' Marketing Authorization Application for Tabe… https://t.co/FSnsIUh0Ly November 30th 2021, 3:11pm |
 |
@Briefingcom $ATRA: Atara Biotherapeutics announces that the Marketing Authorization Application for tabelecleucel has been full… https://t.co/om0GYqXdLo November 30th 2021, 3:11pm |
 |
@MarcJacksonLA https://t.co/oCstLpJA8G | $ATRA European Medicines Agency (EMA) Validates Atara Biotherapeutics' Marketing Authoriz… https://t.co/VMxDtYEQL4 November 30th 2021, 2:11pm |
|
@StockNewsBot2 $ATRA European Medicines Agency (EMA) Validates Atara Biotherapeutics'; Marketing Authorization Application for Tab… https://t.co/QG7Gg3eEWR November 30th 2021, 1:11pm |
|
@quantisnow $ATRA ? European Medicines Agency (EMA) Validates Atara Biotherapeutics' Marketing Authorization Application for Ta… https://t.co/LCi60BBQPO November 30th 2021, 1:11pm |
|
@phasefivebot $ATRA European Medicines Agency (EMA) Validates Atara Biotherapeutics' Marketing Authorization Application for Tabe… https://t.co/QFVsC0iiOv November 30th 2021, 1:11pm |
|
@stock_titan $ATRA European Medicines Agency (EMA) Validates Atara Biotherapeutics'; Marketing Authorization Application for Tab… https://t.co/uqq8gqnz27 November 30th 2021, 1:11pm |
|
@ShortAlgoTrades $ATRA Awaiting BUY signal on the chart from ATRA with https://t.co/Mh6eu0SSsA https://t.co/ZPbtaB8YRm November 29th 2021, 9:11pm |
|
@Tickeron $ATRA in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/5XBzBYG4SH November 28th 2021, 9:11pm |
 |
@investor_feed $ATRA 8-K Atara Biotherapeutics (26 Nov, 5:22pm) ? Other Events; Financial Statements and Exhibits… https://t.co/AjUTyhTuT7 November 26th 2021, 10:11pm |
|
@FlashAlert_me $ATRA [15s. delayed] filed form 8-K on November 26, 17:22:37 https://t.co/63Pob42UxU November 26th 2021, 10:11pm |
|
@newsfilterio Form 424B5 (prospectus [rule 424(b)(5)]) filed with the SEC $ATRA https://t.co/jliswttACs November 26th 2021, 10:11pm |
|
@FlashAlert_me $ATRA [15s. delayed] filed form 424B5 on November 26, 17:20:59 https://t.co/Gfwf0gh0O6 November 26th 2021, 10:11pm |
|
@ShortAlgoTrades $ATRA Awaiting buy signal on ATRA with https://t.co/QwgkByhUfo https://t.co/R9YiE07lmY November 26th 2021, 1:11pm |
|
@ShortAlgoTrades $ATRA Awaiting SHORT signal on ATRA with https://t.co/Mh6eu0SSsA https://t.co/Kj3Fp8pymz November 25th 2021, 10:11pm |
|
@ShortAlgoTrades $ATRA Awaiting BUY signal on XXX with https://t.co/Mh6eu0SSsA https://t.co/KwswOJr6GR November 25th 2021, 10:11pm |
|
@ShortAlgoTrades $ATRA Waiting for short signal on ATRA https://t.co/S9NkhL7rNH November 24th 2021, 12:11pm |
|
@ShortAlgoTrades $ATRA waiting for short signal on ATRA https://t.co/MzSX8zoIds November 23rd 2021, 12:11pm |
 |
@SeekingAlpha $ATRA - Atara Biotherapeutics, Inc. 2021 Q3 - Results - Earnings Call Presentation. https://t.co/9zYQ8vT8Pf #stocks #business #economy November 22nd 2021, 11:11am |
 |
@PMDiChristina Like the way $ATRA is closing the year, good R&R here https://t.co/wQ74EuygH6 November 22nd 2021, 12:11am |
|
@Tickeron Is this good for your portfolio? $ATRA entered Uptrend as Momentum indicator ascends above 0 level.… https://t.co/dwefr10AFg November 20th 2021, 11:11pm |
|
@Tickeron How do you think the market will react to this? $ATRA Stochastic Oscillator left the oversold zone.… https://t.co/tdctFhWZRR November 20th 2021, 8:11pm |
 |
@EnterpriseLeade Atara Biotherapeutics, Inc. $ATRA EVP Jakob Dupont Sells 2,199 Shares https://t.co/SMHgupfE2m November 19th 2021, 4:11pm |
 |
@InsiderForms $ATRA Insider Dupont Jakob has Sold 2,199 Shares. Title :EVP Head of R;D Total Cost: $37,640.06 Buy/Sell : Sell (… https://t.co/HY0N0W07n7 November 18th 2021, 11:11pm |
|
@fintel_io Insider Pascal Touchon reports selling 8,402 shares of $ATRA for a total cost of $143,816.19 https://t.co/hZHgKvh9Xn #FNTL November 18th 2021, 10:11pm |
|
@FlashAlert_me $ATRA [15s. delayed] filed SEC form 4: President and CEO Touchon Pascal: Disposed 8,402 of Common Stock at price $… https://t.co/N0nQmkkBFR November 18th 2021, 10:11pm |
|
@formwhisperscom #FWSells $ATRA Newell Joe, Chief Operations Officer of Atara Biotherapeutics, Inc. sold 3,332 shares on 2021-11-16. https://t.co/OiMnJa21gP November 18th 2021, 10:11pm |
|
@FlashAlert_me $ATRA [15s. delayed] filed SEC form 4: Chief Operations Officer Newell Joe: Disposed 3,332 of Common Stock at pric… https://t.co/mDz1yUM8wd November 18th 2021, 10:11pm |
|
@fintel_io Insider Amar Murugan reports selling 2,124 shares of $ATRA for a total cost of $36,356.30 https://t.co/PhHL8np8dS #FNTL November 18th 2021, 10:11pm |
|
@fintel_io Insider Joe Newell reports selling 3,332 shares of $ATRA for a total cost of $57,033.51 https://t.co/Mm3t2cII5h #FNTL November 18th 2021, 10:11pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?